Tuberous sclerosis (TSC) is an autosomal dominant tumor suppressor gene syndrome, characterized by development of distinctive benign tumors (hamartomas) and malformations (hamartias) in multiple organ systems, due to mutations in either TSC1 or TSC2. The long-term objectives of this project are to understand in detail the functions of the TSC1 and TSC2 genes and proteins, their interacting partners, how they are regulated, and how their loss leads to deregulated growth control in the tumors that develop in TSC patients. The insight achieved will have relevance to growth regulatory mechanisms in general, including in malignant cells. There are four specific aims in this project. First, the importance of phosphorylation at multiple sites on TSC2 by the Akt kinase will be critically tested in vivo through generation and analysis of an allele in the mouse in which these sites are mutated to Ala. Second, we will examine the mechanism and importance in growth control of feedback circuitry in the TSC1/TSC2 signaling pathway that serves to attenuate activation of the Akt kinase when TSC1/TSC2 are lacking, in both cell lines and tumors. Third, we will explore the estrogen responsive growth that is seen in TSC1/TSC2 null cell lines, examining its mechanism, effects on ERa expression and phosphorylation, consequences in terms of gene transcription, and in vivo effects in tumor growth in mice. Fourth, we will examine whether Rheb is the sole downstream effector that is perturbed when TSC1/TSC2 are lacking from cells, whether Rheb activation has the identical effects in cells as the loss of TSC1/TSC2, and identify binding partners of Rheb for downstream signaling effects.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA120964-03
Application #
7799008
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2009-04-01
Budget End
2010-03-31
Support Year
3
Fiscal Year
2009
Total Cost
$433,144
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Cañadas, Israel; Thummalapalli, Rohit; Kim, Jong Wook et al. (2018) Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses. Nat Med 24:1143-1150
Jenkins, Russell W; Aref, Amir R; Lizotte, Patrick H et al. (2018) Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids. Cancer Discov 8:196-215
Limpert, Allison S; Lambert, Lester J; Bakas, Nicole A et al. (2018) Autophagy in Cancer: Regulation by Small Molecules. Trends Pharmacol Sci 39:1021-1032
Tang, Hong-Wen; Hu, Yanhui; Chen, Chiao-Lin et al. (2018) The TORC1-Regulated CPA Complex Rewires an RNA Processing Network to Drive Autophagy and Metabolic Reprogramming. Cell Metab 27:1040-1054.e8
Cox, Andrew G; Tsomides, Allison; Yimlamai, Dean et al. (2018) Yap regulates glucose utilization and sustains nucleotide synthesis to enable organ growth. EMBO J 37:
Chen, Jingjing; Guccini, Ilaria; Di Mitri, Diletta et al. (2018) Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer. Nat Genet 50:219-228
Lewis Jr, Tommy L; Kwon, Seok-Kyu; Lee, Annie et al. (2018) MFF-dependent mitochondrial fission regulates presynaptic release and axon branching by limiting axonal mitochondria size. Nat Commun 9:5008
Eichner, Lillian J; Brun, Sonja N; Herzig, Sébastien et al. (2018) Genetic Analysis Reveals AMPK Is Required to Support Tumor Growth in Murine Kras-Dependent Lung Cancer Models. Cell Metab :
Deng, Jiehui; Wang, Eric S; Jenkins, Russell W et al. (2018) CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation. Cancer Discov 8:216-233
Herzig, Sébastien; Shaw, Reuben J (2018) AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol 19:121-135

Showing the most recent 10 out of 289 publications